OncoSil Medical Limited (ASX:OSL)

OncoSil Medical Revenue

OncoSil Medical had revenue of 985.38K AUD in the half year ending December 31, 2024, with 21.71% growth. This brings the company's revenue in the last twelve months to 1.91M, up 47.09% year-over-year. In the fiscal year ending June 30, 2024, OncoSil Medical had annual revenue of 1.57M with 6.68% growth.

• Revenue (ttm): 1.91M
• Revenue Growth: +47.09%
• P/S Ratio: 9.65
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 18.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.57M	97.96K	6.68%
Jun 30, 2023	1.47M	404.03K	38.00%
Jun 30, 2022	1.06M	-234.94K	-18.10%
Jun 30, 2021	1.30M	-1.47M	-53.02%
Jun 30, 2020	2.76M	-862.28K	-23.78%